Opioids and breast cancer recurrence

Area of Science:

• Oncology
• Pain Management
• Cancer Research

Background:

• Improved breast cancer survival necessitates understanding long-term effects and treatment sequelae.
• Laboratory studies indicate opioids may influence cancer cell growth, but human data on cancer progression is limited.

Purpose of the Study:

• To review recent findings on the relationship between opioid use and breast cancer progression.
• To clarify the controversial association between opioids and breast cancer outcomes.

Main Methods:

• Literature review of recent studies on opioid use and breast cancer.
• Analysis of in-vitro research and observational studies.
• Consideration of ongoing clinical trials comparing anesthesia types.

Main Results:

• Opioid-sparing analgesia may correlate with improved survival in cancer patients.
• In-vitro studies show μ-opioid receptor antagonists can inhibit cancer proliferation and tumor growth.
• Prescription opioid use has not been linked to increased breast cancer recurrence risk in a large observational study.

Conclusions:

• The association between opioids and breast cancer progression remains controversial.
• Further observational studies are required to establish a definitive link.
• There is no clear evidence to advise against opioid use in breast cancer patients due to recurrence concerns.